WAM
STLNW

Wolverine Asset Management’s Starling Oncology Warrant STLNW Stock Holding History

Wolverine Asset Management’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
418,214
+232,777
+126% +$11.1K ﹤0.01% 1381
2026
Q1 		$8.12K Buy
185,437
+4,145
+2% +$399 ﹤0.01% 1443
2025
Q4 		$21.8K Sell
181,292
-15,727
-8% -$2.54K ﹤0.01% 1361
2025
Q3 		$23.6K Buy
197,019
+5,454
+3% +$622 ﹤0.01% 1282
2025
Q2 		$9.83K Buy
191,565
+119,249
+165% +$7.56K ﹤0.01% 1378
2025
Q1 		$1.96K Sell
72,316
-2,404
-3% -$62 ﹤0.01% 1430
2024
Q4 		$388 Hold
74,720
– – ﹤0.01% 1552
2024
Q3 		$1.49K Hold
74,720
– – ﹤0.01% 1491
2024
Q2 		$1.97K Buy
74,720
+20,150
+37% +$1.55K ﹤0.01% 1495
2024
Q1 		$10.9K Sell
54,570
-11,539
-17% -$2.63K ﹤0.01% 1280
2023
Q4 		$13.2K Sell
66,109
-11,789
-15% -$1.86K ﹤0.01% 1359
2023
Q3 		$7.16K Sell
77,898
-5,644
-7% -$459 ﹤0.01% 1521
2023
Q2 		$2.33K Buy
83,542
+200
+0.2% +$11 ﹤0.01% 1562
2023
Q1 		$5.42K Sell
83,342
-10,290
-11% -$1.27K ﹤0.01% 1535
2022
Q4 		$10.3K Sell
93,632
-10,058
-10% -$3.28K ﹤0.01% 1624
2022
Q3 		$57K Sell
103,690
-14,976
-13% -$10.4K ﹤0.01% 1565
2022
Q2 		$59K Buy
118,666
+26,700
+29% +$24.6K ﹤0.01% 1525
2022
Q1 		$105K Sell
91,966
-21,320
-19% -$19.4K ﹤0.01% 1295
2021
Q4 		$78K Buy
+113,286
New +$140K ﹤0.01% 1424

Other funds holding STLNW

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wolverine Asset Management's STLNW Position: Q2 2026 in Review

Wolverine Asset Management increased its Starling Oncology Warrant (STLNW) stake by 126% in Q2 2026, buying an estimated $11.1K and bringing the position to 418,214 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Wolverine Asset Management first reported a position in STLNW in Q4 2021 and has held it in 19 quarters since. The position peaked at $105K in Q1 2022. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.

  • Wolverine Asset Management held 418,214 shares of Starling Oncology Warrant worth $17.1K as of Q2 2026.
  • Wolverine Asset Management bought 232,777 Starling Oncology Warrant shares in Q2 2026, an estimated $11.1K.
  • Starling Oncology Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1381 holding.
  • Wolverine Asset Management first reported a position in Starling Oncology Warrant in Q4 2021 and has held it in 19 quarters since.
  • Wolverine Asset Management's Starling Oncology Warrant position peaked at $105K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.